Mark For: EYENOVIA® trademark registration is intended to cover the categories of
Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 97011367 |
Registration Number | 6760308 |
Mark Literal Elements | EYENOVIA |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | TRADEMARK. SERVICE MARK |
Register | PRINCIPAL |
Current Location | NEW APPLICATION PROCESSING 2021-09-07 |
Basis | 1(a) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | Yes |
Current Use | Yes |
Intent To Use | No |
Filed ITU | No |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Karen Won |
Attorney Docket Number | 054216-401 |
2016-08-00 | Date of First Use |
2016-08-01 | Date of First Use |
2016-08-01 | Date of Use In Commerce |
2021-09-03 | Application Filed |
2021-09-07 | Location: NEW APPLICATION PROCESSING |
2021-09-07 | Status: Live/Pending |
2021-09-07 | Status: New application will be assigned to an examining attorney approximately 6 months after filing date. |
2021-09-07 | Transaction Date |
2022-06-14 | Trademark Registered |
Party: | ![]() |
Address | 295 Madison Ave., Suite 2400 New York, NEW YORK UNITED STATES 10017 |
Legal Entity Type | Corporation |
Legal Entity State | DELAWARE |
![]() | MULTI | 2021-09-03 |
![]() | JPEG | 2021-09-03 |
![]() | JPEG | 2021-09-03 |
IC 005. US 005 006 018 044 046 051 052. G & S: Pharmaceutical preparations for the treatment, prevention, and management of diseases, disorders, and conditions of the eye; pharmaceutical products for use in ophthalmology; therapeutics agents for presbyopia, mydriasis, and myopia; medicated eye drops and eye sprays; drug and drug delivery system, namely, ophthalmic spray dispenser sold filled with pharmaceuticals. FIRST USE: 20160800. FIRST USE IN COMMERCE: 20160800
IC 042. US 100 101. G & S: Research and development services in the fields of ophthalmology, ocular pharmaceuticals, and ophthalmic drug delivery technologies; providing medical scientific research information in the fields of ophthalmology, ocular pharmaceuticals, and ophthalmic drug delivery technologies. FIRST USE: 20200800. FIRST USE IN COMMERCE: 20200800
International Codes: | 5 |
U.S. Codes: | 005,006,018,044,046,051,052 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0051 | Pharmaceutical preparations for the treatment, prevention, and management of diseases, disorders, and conditions of the eye; pharmaceutical products for use in ophthalmology; therapeutics agents for presbyopia, mydriasis, and myopia; medicated eye drops and eye sprays; drug and drug delivery system, namely, ophthalmic spray dispenser sold filled with pharmaceuticals |
GS0051 | Pharmaceutical preparations for the treatment, prevention, and management of diseases, disorders, and conditions of the eye; pharmaceutical products for use in ophthalmology; therapeutics agents for presbyopia, mydriasis, and myopia; medicated eye drops and eye sprays; drug and drug delivery system, namely, ophthalmic spray dispenser sold filled with pharmaceuticals |
Description | Date | Proceeding Number |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2021-09-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.